Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2117391 | 0.87 | PTGDR (0.79) | PTGDRPTGIR | |
| Bicarbonate SCHEMBL16857988 | 0.86 | PTGDR (0.60) | PTGDRPTGIR | |
| SCHEMBL2116874 | 0.86 | PTGDR (0.60) | PTGDRPTGIR | |
| SCHEMBL2118167 | 0.86 | PTGDR (0.60) | PTGDRPTGIR | |
| SCHEMBL2120751 | 0.85 | PTGDR (0.70) | PTGDRPTGIR | |
| SCHEMBL2118148 | 0.85 | PTGDR (0.58) | PTGDRPTGIR | |
| SCHEMBL2117387 | 0.85 | PTGDR (0.58) | PTGDRPTGIR | |
| SCHEMBL2117397 | 0.85 | PTGDR (0.80) | PTGDRPTGIR | |
| SCHEMBL2118058 | 0.85 | PTGDR (0.65) | PTGDRPTGIR | |
| SCHEMBL2117204 | 0.84 | PTGDR (0.70) | PTGDRPTGIR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130225808-A1 | PHENYLACETIC ACID COMPOUND | ONO PHARMACEUTICAL CO., LTD. (JP) | 2013-08-29 | — | — | US | disclosed |
| EP-2177513-A1 | PHENYLACETIC ACID COMPOUND | ONO Pharmaceutical Co., Ltd. (JP) | 2010-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225808-A1 | PHENYLACETIC ACID COMPOUND | PC, PAH, PDHA2 | PTGDR 1630/4885PTGIR 3123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.